Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$2.83 - $8.69 $47,077 - $144,558
-16,635 Closed
0 $0
Q4 2021

Mar 25, 2022

BUY
$8.31 - $14.92 $138,236 - $248,194
16,635 New
16,635 $203,000
Q4 2021

Feb 08, 2022

SELL
$8.31 - $14.92 $138,236 - $248,194
-16,635 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$9.15 - $13.28 $152,210 - $220,912
16,635 New
16,635 $193,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.6B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Privium Fund Management (Uk) LTD Portfolio

Follow Privium Fund Management (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management (Uk) LTD with notifications on news.